On October 5, 2023, an important study, published in JAMA and authored by Mohit Sodhi, indicated an increased risk of gastroparesis, bowel obstruction, and pancreatitis for those using GLP-1 agonists
Patients across Miami, Fort Lauderdale, Boca Raton, Orlando, Tampa, and Jacksonville are increasingly turning to telehealth providers to navigate insurance approvals and start treatment faster
Author CK was employed by Kelly Statistical Consulting
Addressing only one factor: Although GLP-1s target hormonal imbalances, they cannot address the broader spectrum of factors contributing to weight management
Yes, Ozempic may be prescribed off-label for weight loss in non-diabetic individuals, but it should only be used under the supervision of a healthcare provider
Pros: comprehensive support and meal planning